(PR-inside.com) Mitomics Inc. (Mitomics) is a medical diagnostic device manufacturing company. The company researches and develops mitochondrial genome based products to improve clinical insight and therapeutic decisions. Its pipeline products provide solutions for prostate cancer, breast cancer, uterine cancer, cervical cancer, ovarian cancer, pancreatic cancer, endometriosis, melanoma, skin cancer and other dermatological conditions. Mitomics's Prostate Mitomic Test is a blood-based screening test for the prediction of prostate cancer following a PSA level. The company's Endometrial Mitomic Test is also blood-based screening test to identify endometriosis in patients and women of reproductive age. It was formerly known as Genesis Genomics Inc. Mitomics ..